Literature DB >> 16040990

Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp.

Tatiana Voza1, Ana M Vigário, Elodie Belnoue, Anne Charlotte Grüner, Jean-Christophe Deschemin, Michèle Kayibanda, Florian Delmas, Chris J Janse, Blandine Franke-Fayard, Andrew P Waters, Irène Landau, Georges Snounou, Laurent Rénia.   

Abstract

Recent epidemiological observations suggest that clinical evolution of Plasmodium falciparum infections might be influenced by the concurrent presence of another Plasmodium species, and such mixed-species infections are now known to occur frequently in residents of most areas of endemicity. We used mice infected with P. berghei ANKA (PbA), a model for cerebral malaria (CM), to investigate the influence of experimental mixed-species infections on the expression of this pathology. Remarkably, the development of CM was completely inhibited by the simultaneous presence of P. yoelii yoelii but not that of P. vinckei or another line of P. berghei. In the protected coinfected mice, the accumulation of CD8(+) T cells in the brain vasculature, a pivotal step in CM pathogenesis, was found to be abolished. Protection from CM was further found to be associated with species-specific suppression of PbA multiplication. These observations establish the concept of mixed Plasmodium species infections as potential modulators of pathology and open novel avenues to investigate mechanisms implicated in the pathogenesis of malaria.

Entities:  

Mesh:

Year:  2005        PMID: 16040990      PMCID: PMC1201245          DOI: 10.1128/IAI.73.8.4777-4786.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Malaria diagnosis by the polymerase chain reaction: a field study in south-eastern Venezuela.

Authors:  M Postigo; A Mendoza-León; H A Pérez
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Sep-Oct       Impact factor: 2.184

2.  Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria.

Authors:  R N Price; F Nosten; C Luxemburger; M van Vugt; L Phaipun; T Chongsuphajaisiddhi; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

Review 3.  Regulation of immune responses by TGF-beta.

Authors:  J J Letterio; A B Roberts
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis.

Authors:  D N Irani; D E Griffin
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

5.  Patterns of acquired anti-malarial immunity in Sri Lanka.

Authors:  D M Gunewardena; R Carter; K N Mendis
Journal:  Mem Inst Oswaldo Cruz       Date:  1994       Impact factor: 2.743

6.  The epidemiology of severe malaria in an area of low transmission in Thailand.

Authors:  C Luxemburger; F Ricci; F Nosten; D Raimond; S Bathet; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 May-Jun       Impact factor: 2.184

7.  Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.

Authors:  V Amani; M I Boubou; S Pied; M Marussig; D Walliker; D Mazier; L Rénia
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  High incidence of malaria in alpha-thalassaemic children.

Authors:  T N Williams; K Maitland; S Bennett; M Ganczakowski; T E Peto; C I Newbold; D K Bowden; D J Weatherall; J B Clegg
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

9.  Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity.

Authors:  G J Southan; C Szabó; C Thiemermann
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

Authors:  B M Segal; B K Dwyer; E M Shevach
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  14 in total

Review 1.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

2.  Antimalarial activity of allicin, a biologically active compound from garlic cloves.

Authors:  Alida Coppi; Melissa Cabinian; David Mirelman; Photini Sinnis
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.

Authors:  Erik W Settles; Lindsey A Moser; Tajie H Harris; Laura J Knoll
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

4.  Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

Authors:  Elodie Belnoue; Tatiana Voza; Fabio T M Costa; Anne Charlotte Grüner; Marjorie Mauduit; Daniela Santoro Rosa; Nadya Depinay; Michèle Kayibanda; Ana Margarida Vigário; Dominique Mazier; Georges Snounou; Photini Sinnis; Laurent Rénia
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

5.  Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination.

Authors:  Nicolas Steenkeste; William O Rogers; Lucy Okell; Isabelle Jeanne; Sandra Incardona; Linda Duval; Sophy Chy; Sean Hewitt; Monidarin Chou; Duong Socheat; François-Xavier Babin; Frédéric Ariey; Christophe Rogier
Journal:  Malar J       Date:  2010-04-22       Impact factor: 2.979

6.  Alpha-tocopherol transfer protein gene inhibition enhances the acquired immune response during malaria infection in mice.

Authors:  Maria Shirley Herbas; Magloire Hamtandi Natama; Hiroshi Suzuki
Journal:  Parasitol Res       Date:  2013-12-21       Impact factor: 2.289

7.  Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei.

Authors:  Alexis N LaCrue; Misty Scheel; Katherine Kennedy; Nikesh Kumar; Dennis E Kyle
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 8.  Role of interleukin-10 in malaria: focusing on coinfection with lethal and nonlethal murine malaria parasites.

Authors:  Mamoru Niikura; Shin-Ichi Inoue; Fumie Kobayashi
Journal:  J Biomed Biotechnol       Date:  2011-11-13

9.  Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.

Authors:  Claudia M Egima; Silene F Macedo; Gisela Rs Sasso; Charles Covarrubias; Mauro Cortez; Fernando Y Maeda; Fabio T Costa; Nobuko Yoshida
Journal:  Malar J       Date:  2007-07-09       Impact factor: 2.979

10.  Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria.

Authors:  Dieudonnée Togbe; Paulo Loureiro de Sousa; Mathilde Fauconnier; Victorine Boissay; Lizette Fick; Stefanie Scheu; Klaus Pfeffer; Robert Menard; Georges E Grau; Bich-Thuy Doan; Jean Claude Beloeil; Laurent Renia; Anna M Hansen; Helen J Ball; Nicholas H Hunt; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.